rs663532

Variant names:

• chr10-6427794-T-C
• rs663532
• NM_006257.5:c.*413A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_Strong BS1 BS2

The NM_006257.5(PRKCQ):​c.*413A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0173 in 194,276 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency:
  • Genomes: 𝑓 0.019 (45 hom., cov: 33)
  • Exomes 𝑓: 0.012 (3 hom.)
• Consequence: PRKCQ NM_006257.5 3_prime_UTR
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.811
• Publications: 4 publications found

Genes affected

PRKCQ (HGNC:9410): (protein kinase C theta) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and the second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC family members also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play a distinct role. The protein encoded by this gene is one of the PKC family members. It is a calcium-independent and phospholipid-dependent protein kinase. This kinase is important for T-cell activation. It is required for the activation of the transcription factors NF-kappaB and AP-1, and may link the T cell receptor (TCR) signaling complex to the activation of the transcription factors. [provided by RefSeq, Jul 2008]

ENSG00000302067 (HGNC:):

ACMG classification

Our verdict: Benign. The variant received -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.89).
• BS1: Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0188 (2859/152294) while in subpopulation AFR AF = 0.0306 (1271/41554). AF 95% confidence interval is 0.0292. There are 45 homozygotes in GnomAd4. There are 1432 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
• BS2: High AC in GnomAd4 at 2859 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006257.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	PRKCQ	NM_006257.5	MANE Select	c.*413A>G		3_prime_UTR	Exon 18 of 18	NP_006248.1	Q04759-1
	PRKCQ	NM_001323265.1		c.*413A>G		3_prime_UTR	Exon 18 of 18	NP_001310194.1	Q04759-1
	PRKCQ	NM_001282644.2		c.*413A>G		3_prime_UTR	Exon 18 of 18	NP_001269573.1

Ensembl Transcripts

Sel.	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	PRKCQ	ENST00000263125.10	TSL:1 MANE Select	c.*413A>G		3_prime_UTR	Exon 18 of 18	ENSP00000263125.5	Q04759-1
	PRKCQ	ENST00000915286.1		c.*413A>G		3_prime_UTR	Exon 18 of 18	ENSP00000585345.1
	PRKCQ	ENST00000866196.1		c.*413A>G		3_prime_UTR	Exon 18 of 18	ENSP00000536255.1

Frequencies

GnomAD3 genomes AF: 0.0188 AC: 2854 AN: 152176 Hom.: 44 Cov.: 33

Gnomad AFR AF: 0.0305

Gnomad AMI AF: 0.0582

Gnomad AMR AF: 0.00524

Gnomad ASJ AF: 0.00778

Gnomad EAS AF: 0.00404

Gnomad SAS AF: 0.0242

Gnomad FIN AF: 0.0200

Gnomad MID AF: 0.00949

Gnomad NFE AF: 0.0154

Gnomad OTH AF: 0.0125

GnomAD4 exome AF: 0.0119 AC: 498 AN: 41982 Hom.: 3 Cov.: 0 AF XY: 0.0118 AC XY: 259 AN XY: 21892

African (AFR) AF: 0.0326 AC: 14 AN: 430

American (AMR) AF: 0.00525 AC: 18 AN: 3426

Ashkenazi Jewish (ASJ) AF: 0.00750 AC: 6 AN: 800

East Asian (EAS) AF: 0.00429 AC: 5 AN: 1166

South Asian (SAS) AF: 0.0165 AC: 112 AN: 6780

European-Finnish (FIN) AF: 0.0137 AC: 30 AN: 2186

Middle Eastern (MID) AF: 0.00 AC: 0 AN: 144

European-Non Finnish (NFE) AF: 0.0118 AC: 293 AN: 24846

Other (OTH) AF: 0.00907 AC: 20 AN: 2204

GnomAD4 genome AF: 0.0188 AC: 2859 AN: 152294 Hom.: 45 Cov.: 33 AF XY: 0.0192 AC XY: 1432 AN XY: 74458

African (AFR) AF: 0.0306 AC: 1271 AN: 41554

American (AMR) AF: 0.00523 AC: 80 AN: 15300

Ashkenazi Jewish (ASJ) AF: 0.00778 AC: 27 AN: 3470

East Asian (EAS) AF: 0.00386 AC: 20 AN: 5186

South Asian (SAS) AF: 0.0242 AC: 117 AN: 4830

European-Finnish (FIN) AF: 0.0200 AC: 212 AN: 10610

Middle Eastern (MID) AF: 0.00680 AC: 2 AN: 294

European-Non Finnish (NFE) AF: 0.0154 AC: 1051 AN: 68030

Other (OTH) AF: 0.0123 AC: 26 AN: 2110

Alfa AF: 0.0231 Hom.: 4

Bravo AF: 0.0171

Asia WGS AF: 0.0190 AC: 65 AN: 3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.89
CADD	Benign	0.47
DANN	Benign	0.34
PhyloP100		-0.81
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs663532; hg19: chr10-6469756;